From: Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti
EPIDEMIOLOGIC/PROGRAMME DATA | HAITI | REFERENCE/SOURCE | Â |
---|---|---|---|
Population (2002) | 8.3 million | [9] | |
Gross National Income annual per capita (US$) | $ 440 | [9] | |
Life expectancy at birth | 52.0 | [9] | |
All cause mortality | Age specific | [44] | |
Incidence new smear positive TB per 100,000 (2001) | 138 | [8] | |
Annual risk of TB infection (ARI) | 2.26% | Calculated from [14] and [8] | |
Prevalence of LTBI at age 20 | 41% | Calculated from [14] | |
Likelihood of diagnosis and treatment of LTBI | 1% | [59] * | |
Completion of LTBI Treatment | 67% | [60] | |
Efficacy of 9 INH – INH Sensitive | 90% | [61] | |
INH Resistant | 0 | [62] | |
Prevalence of HIV infection – 2002 | 4.5% | [10] | |
Incidence of HIV infection | 0.46%/year | Calculated from [35] | |
DOTS Coverage – 2002 | 37% | [11] | |
Case detection rate – 2001 | 49% | [8] | |
Drug Resistance | Â | Â | Â |
   Single drug resistance | 20% (11%-31%) | [12] | |
   Multi drug resistance (HR) | 0.3% (0–4%) | [12;63] | |
Treatment outcomes New cases – 2001 | Overall [8] | DOTS areas (NTP) | Non-DOTS |
   Cure/complete | 71% | 85% | 63% |
   Default/transfer/not evaluated | 23% | 9% | 31% |
   Die | 5% | 5% | 5% |
   Fail | 1% | 1% | 1% |
Outcomes Re-treatment cases – 2001 | Overall [8] | DOTS areas (NTP) | Non-DOTS |
   Cure/complete | 54% | 80% | 39% |
   Default/transfer/not evaluated | 29% | 4% | 44% |
   Die | 8% | 8% | 8% |
   Fail | 8% | 8% | 8% |